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Background: The biogenesis of melanosomes and other lysosome-related organelles requires a pair of Rab GTPases, Rab32
and Rab38.
Results: Myosin Vc is a novel binding partner of these Rabs. Myosin Vc functions in the trafficking of integral membrane
proteins to melanosomes.
Conclusion: Myosin Vc works in transport to and secretion of melanosomes.
Significance: These results advance understanding of melanosome biology.
Class V myosins are actin-based motors with conserved func-
tions in vesicle and organelle trafficking. Herein we report the
discovery of a function for Myosin Vc in melanosome biogenesis
as an effector of melanosome-associated Rab GTPases. We iso-
lated Myosin Vc in a yeast two-hybrid screening for proteins
that interact with Rab38, a Rab protein involved in the biogen-
esis of melanosomes and other lysosome-related organelles.
Rab38 and its close homolog Rab32 bind to Myosin Vc but not to
Myosin Va or Myosin Vb. Binding depends on residues in the
switch II region of Rab32 and Rab38 and regions of the Myosin
Vc coiled-coil tail domain. Myosin Vc also interacts with Rab7a
and Rab8a but not with Rab11, Rab17, and Rab27. Although
Myosin Vc is not particularly abundant on pigmented melano-
somes, its knockdown in MNT-1 melanocytes caused defects in
the trafficking of integral membrane proteins to melanosomes
with substantially increased surface expression of Tyrp1, nearly
complete loss of Tyrp2, and significant Vamp7 mislocalization.
Knockdown of Myosin Vc in MNT-1 cells more than doubled
the abundance of pigmented melanosomes but did not change
the number of unpigmented melanosomes. Together the data
demonstrate a novel role for Myosin Vc in melanosome biogen-
esis and secretion.
Melanosomes are lysosome-related organelles (LROs)3 that
synthesize and store melanin pigments in skin melanocytes and
retinal pigmented epithelial cells (1–3). The development or
maturation of melanosomes depends on discrete organelle
remodeling and trafficking events and can be classified into
four distinct morphological stages (1, 4). The least mature
melanosomes, stage I, are formed from vacuolar early endo-
somes. Stage I melanosomes are characterized by the presence
of the structural protein Pmel17 (also known as PMEL) on the
organelle limiting membrane and on intraluminal vesicles
within the organelle and by a distinctive clathrin lattice on the
limiting membrane (1, 4). Within the environment of stage I
melanosomes, Pmel17 is cleaved by a furin-type proprotein
convertase and then by a metalloproteinase (1, 5, 6). In stage II
melanosomes, Pmel17 fragments oligomerize and form amy-
loid-like fibrils that span the length of the melanosome and are
clearly evident in electron micrographs (4, 6 – 8). The subse-
quent delivery of integral membrane proteins such as the
enzymes tyrosinase, tyrosinase-related protein 1 (Tyrp1), and
Tyrp2 initiates the synthesis of melanin pigments that coat the
Pmel17-fibrils to form partially pigmented stage III melano-
somes (1). Tyrosinase is the key enzyme for melanin synthesis,
with Tyrp1 and Tyrp2 serving modulatory roles (1, 3, 9). Addi-
tional melanin synthesis generates fully pigmented stage IV
melanosomes (1).
Newly synthesized tyrosinase, Tyrp1, and other cargo
required for melanosome maturation beyond stage II are deliv-
ered from early endosomal tubules and buds (1, 10 –13). This
traffic is complex and involves at least two routes that depend
on adaptor protein-1 (AP-1), AP-3, biogenesis of lysosome-re-
lated organelle complex-1 (BLOC-1), BLOC-2, and BLOC-3 (1,
10 –13). These components of the trafficking machinery are
expressed in all cell types, reflecting their function in ubiqui-
tous trafficking such as transport of lysosome-associated mem-
brane proteins (LAMPs) to the lysosome (14 –20). However,
with the exception of AP-1, whose deficiency causes embryonic
lethality, deficiency in any of these proteins manifests more
noticeably in LRO-producing cell types and underlies various
forms of Hermansky-Pudlak syndrome (14, 21–23). Herman-
sky-Pudlak syndrome is a disorder characterized by hypopig-
mentation due to defective melanosome biogenesis and addi-
tional manifestations caused by deficiencies in other LROs.
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Importantly, two closely related members of the Rab family,
Rab32 and Rab38, interact physically and functionally with
AP-1, AP-3, and the BLOCs to mediate transport of cargo from
early endosomal domains to maturing melanosomes (24 –26).
Rab32 and Rab38 are expressed in a tissue-specific manner, are
chiefly present in LRO-producing cell types, and provide an
elegant mechanistic explanation to the repurposing of the ubiq-
uitous trafficking machinery for LRO biogenesis in specialized
cell types (25, 27–32). Consistently, rodents with mutations in
Rab38 manifest with typical LRO deficiencies such as hypop-
igmentation due to impaired melanosome biogenesis (29,
31–35).
In skin, the stage IV melanosomes are secreted and trans-
ferred from melanocytes to keratinocytes where they remain
and form a pigmented cap around the keratinocyte nucleus (2,
3). Several mechanisms have been proposed to explain the
intercellular melanosome transfer including (i) the Rab11-de-
pendent exocytosis of naked melanin or “melanocore” by mela-
nocytes and subsequent endocytosis by keratinocytes, (ii) the
formation of Rab17-dependent filopodia by melanocytes as
conduits for melanosome transfer, (iii) the release of “globules”
containing several melanosomes that are then taken up by kera-
tinocytes, and (iv) the shedding of melanosome-rich packages
subsequently phagocytosed by keratinocytes (36 – 41). The
melanosome secretion and/or transfer mechanism is currently
debated at a morphological level, and with the possible excep-
tion of Rab11 and Rab17, the molecular machinery involved is
unknown. However, it is clear that before secretion and inter-
cellular transfer can occur, stage IV melanosomes must move
on microtubules to the cell periphery and be captured by the
cortical actin cytoskeleton. Rab27a and the actin-based motor
Myosin Va localize to and interact on stage IV melanosomes to
mediate their association with the cortical actin close to the
plasma membrane (42– 45). The interaction between Rab27a
and Myosin Va is mediated by melanophilin rather than direct
(46, 47). Deficiency in Rab27a, Myosin Va, or melanophilin
does not affect melanosome biogenesis but results in perinu-
clear clustering of mature melanosomes and diminished trans-
fer to keratinocytes (42–51). Griscelli syndrome patients and
the corresponding mice models have mutations in Rab27a,
Myosin Va, or melanophilin and display hypopigmentation due
to inefficient peripheral capture and subsequent transfer of
melanosomes to keratinocytes (21). Myosin Va belongs to a
family of well conserved actin-associated motors that function
in vesicle and organelle trafficking events from yeast to humans
(52). The other members of the mammalian class V Myosin
family are Myosin Vb and Myosin Vc. Myosin Vb functions
with Rab11 and Rab8 in the ubiquitous recycling of cargoes
such as the transferrin receptor from early/recycling endo-
somal domains to the plasma membrane (53). Myosin Vc has
been less well characterized but localizes to early/recycling
endosomal domains in non-specialized cells and to secretory
organelles in specialized cell types (53–56). To our knowledge
no functional binding partner of Myosin Vc has been described
to date.
Here we report that Myosin Vc interacts with Rab32, and
Rab38 and functions in melanosome biogenesis and secretion.
Myosin Vc functions in the trafficking of integral membrane
proteins to melanosomes including Tyrp1, Tyrp2, and Vamp7.
Myosin Vc deficiency also causes accumulation of pigmented
melanosomes in melanocytes, but Myosin Vc is not abundant
on pigmented melanosomes, suggesting an indirect role in
melanosome secretion.
EXPERIMENTAL PROCEDURES
Plasmids, Antibodies, and Yeast Two-hybrid Assay—The
cDNA encoding for human Rab7a, Rab8a, Rab11a, Rab17,
Rab27a, Rab32, Rab38, and Myosin Va full tail (encoding for aa
908 –1855, gene ID 4644) were amplified from total RNA of
MNT-1 cells by reverse transcriptase-PCR and subsequently
cloned in-frame into pGBT9 and pGAD424 vectors (Clontech).
The cDNA encoding for full-length human Myosin Vb was
obtained from Promega Kazusa ORFs (pF1K-hMyo5b, gene ID
4645) and the corresponding full tail (encoding for aa 905–
1848) amplified by PCR and cloned in-frame into pGAD424
vector. Plasmids for overexpression of human Myosin Vc-GFP
full-length and full tail (encoding for aa 898 –1742) were previ-
ously described (54, 55). The constructs encoding for Myosin
Vc full-length and full tail utilized in this study correspond to
the gene ID 55930 sequence and contained all exons that in
other Myosin V family members are alternatively spliced (exons
D, E, and F). The cDNA for Myosin Vc full tail was subcloned
into the pGAD424 vector, and the cDNA for Myosin Vc glob-
ular tail (aa 1335–1742) was amplified by PCR and cloned into
pGAD424. The cDNA for human tyrosinase and tyrp1 were
amplified from total RNA of MNT-1 cells by reverse transcrip-
tase-PCR and subsequently cloned in-frame into pmCherry.
Site-directed mutagenesis of plasmids encoding for the Rab
proteins was performed using the QuikChange system (Strata-
gene, La Jolla, CA). Deletion of Myosin Vc tail regions (exon D,
E, and F) was achieved by the overlapping PCR method. Anti-
bodies used were as follows: rabbit a-Myosin Va (57), chicken
a-Myosin Vb (54), rabbit a-Myosin Vc (54), mouse a-tyrosinase
(Santa Cruz, T311), mouse a-Tyrp1 (Santa Cruz, MEL5, clone
Ta99), mouse a-Tyrp2 (Santa Cruz, C-9), mouse a-Pmel17
(Dako, HMB45), mouse a-Vamp7 (Abcam, SYBL1 clone 158.2),
mouse a-Rab7a (Sigma, Rab7–117), mouse a-Rab8a (BD Biosci-
ences, 610845), mouse a-Rab27a (Santa Cruz, E12A-1), rabbit
a-Rab11a (Invitrogen, 71-5300), rabbit a-Rab32 and rabbit
a-Rab38 (24), and mouse a-tubulin (Sigma, DM1A). Alexa-
488- Alexa-546-, and Alexa-647-conjugated secondary anti-
bodies were from Invitrogen, and horseradish peroxidase-
conjugated secondary antibodies were from GE Healthcare/
Amersham Biosciences. Anti-mouse secondary antibodies
complexed with 12- or 18-nm colloidal gold for transmission
electron microscopy were from Jackson ImmunoResearch.
Yeast two-hybrid experiments were performed using pGBT9
and pGAD424 vectors (Clontech) and AH109 Saccharomyces
cerevisiae cells grown on Synthetic Dropout media lacking leu-
cine and tryptophan as selection markers as previously de-
scribed (58). 3-Amino-1,2,4-triazole was used to test for higher
binding stringency.
Cell Culture—Human MNT-1 cells were cultured as
described (59). Transfection for siRNA and plasmids for over-
expression of GFP- and Cherry-fusion proteins was performed
using the Nucleofector electroporation system (Lonza) and the
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NHEM-Neo kit with MNT-1 cells subcultured 2–3 days before
transfection. Briefly, 1.5  106 cells were subjected to two
sequential siRNAs treatments on days 1 and 4, and cells were
analyzed on day 7. Cells transfected with plasmids for GFP-
fusion protein overexpression (1.5  106 cells per transfection)
were analyzed after 48 h. Oligonucleotides used for siRNA are
as follows: Myosin Vc (Sigma; SASI_Hs01_00184026), Rab32
(Sigma; SASI_Hs02_00342400), Rab38 (Sigma; SASI_Hs01_
00247037),  subunit of AP-3 (12), and universal negative con-
trol siRNA (Sigma; SIC001). Transfection efficiency of plasmids
was 70% or higher as judged by the percentage of cells display-
ing fluorescence upon microscopy observation.
Biochemical Procedures—Whole cell extracts were prepared
as previously described (60). For immunoblotting analysis, pro-
teins were fractionated on pre-cast 4 –20% gradient SDS/poly-
acrylamide gels (Invitrogen) and transferred by electroblotting
to PVDF membranes. Membranes were incubated sequentially
with blocking buffer, primary antibody, and horseradish perox-
idase-conjugated secondary antibody as described (61). Bound
antibodies were detected by using ECL Prime Western blotting
reagent (GE Healthcare/Amersham Biosciences). For subcellu-
lar fractionation, a post-nuclear supernatant was prepared by
homogenizing MNT-1 cells with a Dounce homogenizer in
buffer H (20 mM Hepes, pH 7.4) containing 0.32 M sucrose and
protease inhibitors followed by centrifugation for 20 min at
800  g at 4 °C. The post-nuclear supernatant (250 l) was
loaded onto a 12-ml linear sucrose gradient (20 –55%) in buffer
H. The sample was centrifuged at 113,000  g for 6 h in a
SW41Ti rotor in a Beckman L8 –70 M ultracentrifuge at 4 °C.
Fractions of 1 ml were collected and used for immunoblotting.
Melanin Content—MNT-1 cells were centrifuged at 90  g
for 10 min to pellet cells. Cell pellets were solubilized with Sou-
lene 350 (PerkinElmer Life Sciences) and treated and analyzed
as described (62) by a spectrophotometric method at 500 nm
using purified Sepia officinalis melanin (Sigma) as a standard.
Melanin secreted by MNT-1 cells to the culture media was
determined as follows. After siRNA or plasmid transfection, the
monolayer of MNT-1 cells was carefully washed with media to
eliminate cells loosely attached to the culture dish, and fresh
medium was added for a final 24-h incubation period. Culture
media was collected and subjected to ultracentrifugation at
400,000  g for 15 min at 4 °C, and the resulting pellets were
treated as described for solubilization and melanin determina-
tion (62). The melanin content was normalized to the protein
content in the cell monolayer, which was established in a Triton
X-100 lysate by the Bradford method using a commercial kit
(Bio-Rad) and BSA as standard.
Electron Microscopy—High pressure freezing was performed
as previously described (63, 64). Briefly, MNT-1 cells treated
with control or Myosin Vc siRNA were subjected to high pres-
sure freezing in 15% dextran (9 –11 kDa) in culture media,
freeze-substitution in 0.25% glutaraldehyde, 0.1% uranyl ace-
tate, and embedding in Lowicryl HM20 resin and processed for
thin-section transmission electron microscopy. For immuno-
gold labeling, 80-nm sections were collected on nickel slot
grids, blocked with 20% goat serum in PBS, blotted, and then
incubated in the primary antibodies overnight at 4 °C. Grids
were washed in PBS-Tween and incubated in the secondary
antibodies for 1.5 h. Anti-mouse secondary antibody com-
plexed with 12-nm colloidal gold was used for detection of
Pmel17. Anti-mouse secondary antibody complexed with
18-nm colloidal gold was used for detection of Vamp7. Grids
were washed first in PBS-Tween and then in PBS, fixed in 0.5%
glutaraldehyde in PBS, washed in distilled H2O, and dried. The
grids were stained with 2% uranyl acetate in 70% methanol, 30%
water for 7 min, rinsed in 70% methanol, 30% water, dried, and
then post-stained in Reynold’s lead stain, rinsed in distilled
H2O, and dried. Images were taken on a JEOL 2000 TEM.
Live Cell Microscopy, Immunofluorescence Microscopy, and
Antibody Internalization Assay—For live cell imaging experi-
ments cells were plated on Matrigel-coated glass-bottom
35-mm dishes. The samples were imaged using a temperature-
controlled chamber at 37 °C and 5% CO2 on an Olympus IX81
spinning-disk confocal fluorescence microscope with Photo-
metrics Cascade II camera using a 100/1.40NA objective. For
immunofluorescence microscopy cells were grown on Matri-
gel-coated coverslips and fixed in a 50/50 mixture of cold
(20 °C) methanol/acetone at room temperature for 10 min,
allowed to dry, and stored in PBS containing 0.1% sodium azide
at 4 °C. Cells were permeabilized and blocked, incubated with
primary antibody for 1 h, and incubated with species-specific
secondary antibodies conjugated to Alexa-488, Alexa-546, or
Alexa-647 (Invitrogen). Internalization of antibodies was per-
formed as described (12, 17). Briefly, MNT1 cells transfected
with siRNA or plasmids were grown on glass coverslips and
incubated for 20 min at 37 °C in the presence of mouse a-Tyrp1
primary antibody diluted in DMEM, 1% (w/v) BSA, 25 mM
HEPES buffer, pH 7.4. Subsequently cells were washed for 5
min in ice-cold PBS, fixed in 2% formaldehyde for 10 min, incu-
bated for 1 h at room temperature in the presence of Alexa-488-
or Alexa-647-labeled a-mouse secondary antibody (diluted in
PBS, 0.1% (w/v) BSA, 0.1% (w/v) saponin), rinsed with PBS, and
mounted onto glass slides with Fluoromount G. Tyrp1 surface
expression represents the relative fluorescence intensity of each
siRNA treatment versus control (irrelevant siRNA; see Fig. 7B)
or each GFP-fusion protein versus control (GFP; see Fig. 7C)
corrected for the corresponding overall level of Tyrp1 expres-
sion as determined by immunoblotting of total cell extracts. For
live cell imaging of transferrin, MNT-1 cells previously trans-
fected with Myosin Vc-GFP and Myosin Vb-GFP were incu-
bated for 20 min at 37 °C in the presence of 0.16 mg/ml trans-
ferrin-Alexa-647 (Invitrogen) in culture media. Subsequently,
cells were washed in culture media and immediately observed
by spinning disk confocal fluorescence microscopy. Immuno-
fluorescence microscopy samples were examined using the
same microscope described above. Fixed and live cell sample
images were acquired and analyzed in Slidebook 5.0 software
(3i). For determination of the percent of colocalization, each
channel was subjected to a Laplacian 2D filter with a 3  3
kernel (1, 8, 1), and a binary mask was generated using a
Ridler-Calvard automated threshold method both on each
channel and on the overlap between the two individual chan-
nels in Slidebook software. Pixel area overlap from the overlap
mask and each individual mask was used to calculate percent
colocalization. Antibody internalization images were acquired
at room temperature using a Nikon Diaphot 300 microscope
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with Photometrics Cool SNAP camera using Metamorph soft-
ware under conditions optimized to prevent signal saturation.
Images were analyzed for total fluorescence intensity with
ImageJ software (National Institutes of Health) as previously
described (12, 17).
RESULTS
Myosin Vc Interacts with Rab GTPases Involved in Melano-
some Biogenesis—Previous work identified the closely related
Rab32 and Rab38 as key components in the biogenesis of mela-
nosomes, platelet dense granules, and other LROs. To identify
novel binding partners of Rab38, a human bone marrow expres-
sion library was screened with the constitutively active (GTP-
locked) human Rab38-Q69L mutant using the yeast two-hybrid
system. Six colonies that grew in the absence of histidine and
presence of 5 mM 3-amino-1,2,4-triazole were isolated. One of
them, displaying the strongest interaction, was further charac-
terized by DNA sequencing. The clone contained a cDNA seg-
ment encoding amino acid residues 901–1350 of Myosin Vc,
spanning most of the coiled-coil part of its tail domain (Fig. 1C,
left side) (54). To validate this result with independent con-
structs, the full tail of Myosin Vc (residues 898 –1742) was
tested and found to interact with the constitutively active,
GTP-locked mutants of Rab32 and Rab38 but not with the wild-
type proteins (Fig. 1A) or the corresponding dominant-negative
mutants Rab38-T23N and Rab32-T39N (not shown). These
interactions were highly specific because constitutively active
Rab32 and Rab38 did not interact with the full tail of the other
human class V Myosins, Myosin Va and Myosin Vb (Fig. 1B).
Conversely, specificity was also demonstrated by the lack of
interaction between the full tail of human Myosin Vc and con-
stitutively active human Rab11a or Rab27a, which are known
binding partners of Myosin Vb and Myosin Va, respectively
(Fig. 1A) (42, 65). Specificity was further supported by the lack
of Myosin Vc interaction with constitutively active human
Rab17 (Fig. 1D).
In melanocytes, Rab7a localizes to immature stage I-III mela-
nosomes and Rab8a to more mature, pigmented melanosomes
and may be involved in melanosome biogenesis (66, 67). There-
fore, we tested for interaction between the constitutively active,
GTP-locked mutant version of these Rabs and Myosin Vc as
well as Myosin Va and Myosin Vb (Fig. 1, A and B). Constitu-
tively active Rab7a and both wild-type and constitutively active
Rab8a interacted with Myosin Vc full tail (Fig. 1A). Rab7a had
the least specificity in binding and was found to bind to all three
human class V Myosins (Fig. 1B). Rab8a interacted with the full
tails of Myosin Vb and Myosin Vc, but not with Myosin Va (Fig.
1B), consistent with a previous report (53). In addition, Rab11a
bound only the tail of Myosin Vb, as previously reported (53),
but at variance with another study reporting interaction with
Myosin Va and Myosin Vb (68), and Rab27a showed no direct
binding to any of the Myosins tested, consistent with the known
necessity of melanophilin for Rab27a-Myosin Va interaction
(43, 47). Therefore, constitutively active Rab32 and Rab38
showed the most specific binding to Myosin Vc, suggesting that
Myosin Vc may function as an effector protein for these Rabs.
Myosin Vc could function as an effector of additional Rabs
(Rab7a and Rab8a) in melanosome biogenesis.
Rabs are known to bind the tail of class V myosins at the
globular region or the coiled-coil region (Fig. 1C) (69, 70). The
Myosin Vc globular tail domain alone did not interact with
Rab32, Rab38, or Rab8 (Fig. 1D). Tissue-specific alternative
splicing of Myosin V-tail exons in the coiled-coil domain is
prevalent and important for regulating specific Rab interac-
tions. For example, in melanocyte cells Myosin Va exists as an
alternatively spliced isoform containing exon F, which is
required for localization to melanosomes. Furthermore, the
interaction between Rab8a and Myosin Vc in HeLa cells
appears to depend on exon D (43, 69). Consequently, homolo-
gous exon sequences in the tail of Myosin Vc (naming is based
on alignment with Myosin Va and Myosin Vb (54, 71)) were
removed from the full-length tail and tested in yeast two-hybrid
assays with Rab7a, Rab8a, Rab32, and Rab38 (Fig. 1C). Rab32
and Rab38 were found to have partially overlapping binding
sites requiring exon F (Fig. 1C). Rab8a and Rab38 were also
found to have partially overlapping binding sites requiring exon
E (Fig. 1C). Of the Rabs tested, Rab8a was the only one requiring
exon D for binding (Fig. 1C). Binding of Rab7a could not be
mapped to any of these exons, but Rab7a turned out to be capa-
ble of binding to both the coiled-coil and globular domains in
the tail of Myosin Vc (Fig. 1, C and E). It is not known if Myosin
Vc is alternatively spliced in other tissues, but we found that in
MNT-1 melanocytes the only isoform of Myosin Vc detected
contained all of the exons D, E, and F. Therefore, Myosin Vc
may be able to bind simultaneously to specific Rabs with non-
overlapping binding sites (Fig. 1, C and E).
Myosin Vc Binds to a Canonical Effector Binding Surface on
Rab32 and Rab38 —The interaction between Rabs and effector
proteins depends on exposed hydrophobic residues in the Rab
switch I and switch II regions and an adjacent hydrophobic
triad (71, 72). Because the switch conformation serves as a read-
out for the nucleotide status, Rab effector proteins must bind to
this region to discriminate between active (GTP-bound) and
inactive (GDP-bound) forms of the GTPase. A previously
known effector of Rab32 and Rab38, Varp, interacts with the
switch II region of these Rabs (73). Site-directed mutagenesis
was performed for amino acids in the switch I, switch II, and
hydrophobic triad regions, and a sub-family specific loop,
shared by Rab32, Rab38, and Rab9a was deleted (72). Fig. 2A
shows a model of the predicted Rab32 three-dimensional struc-
ture highlighting residues subjected to mutagenesis (purple and
yellow residues); the homologous residues were also mutated in
Rab38. The ability of both sets of mutants to interact with the
tail of Myosin Vc was tested using the yeast two-hybrid system
(Fig. 2). Mutation of the tyrosine residue present in the switch II
region of Rab32 (Y95A) and Rab38 (Y79A) disrupted the inter-
action of both Rabs with Myosin Vc (Fig. 2, A and B). The
adjacent residue in the switch II region (Val-94 in Rab32 and
Val-78 in Rab38) was shown to participate in the binding of
Rab32 and Rab38 to Varp (Fig. 2A, green residue) (73). We,
therefore, mutated the valine residue in both Rab32 and Rab38
and tested for its effect on the interaction with Myosin Vc (Fig.
2C). Mutation of the valine residue individually did not appear
to decrease binding of Rab32 or Rab38 to Myosin Vc, but the
combined mutation of adjacent valine and tyrosine residues
resulted in a loss of interaction with Myosin Vc that was greater
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than the effect of the tyrosine residue alone (Fig. 2C). From
these experiments we conclude that Myosin Vc and Varp utilize
an overlapping binding site in the switch II region of Rab32 and
Rab38.
Myosin Vc Deficiency Causes the Accumulation of Pigmented
Melanosomes—The interaction between Myosin Vc and Rab32
and Rab38 suggested a role for Myosin Vc in melanosome bio-
genesis or function. To test this possibility, siRNA-mediated
knockdown against Myosin Vc was performed in MNT-1 mela-
nocytes. Importantly, although significant Myosin Vc defi-
ciency was achieved, related proteins Myosin Va or Myosin Vb
were not knocked down (Fig. 3A). Instead, knockdown of Myo-
sin Vc resulted in an increase in the abundance of both Myosin
Va and Myosin Vb (Fig. 3A). It was found that deficiency of
FIGURE 1. Interaction of Myosin Vc with Rab proteins involved in melanosome biogenesis. Yeast two-hybrid assays with the full-tail of human Myosin Va
(aa 908 –1855), Myosin Vb (aa 905–1848), and Myosin Vc (aa 898 –1742) binding to human Rab GTPases associated with melanosome biogenesis in the
GTP-locked, constitutively active state (Q-L mutations) is shown. Yeast cells (AH109) were co-transformed with expression plasmids containing GAL4 activation
(PGAD424) and DNA binding (PGBT9) domains fused in-frame to the indicated Myosin V fragments and Rab proteins, respectively. Double transformants were
first selected on minimal media lacking leucine and tryptophan and containing histidine (his) and then spotted onto plates containing the same medium (as
control) or selective medium lacking histidine and containing various concentrations of 3-amino-1,2,4-triazole (3-AT). Cell growth in panels lacking histidine
indicates physical interaction between Myosin V and Rabs. Growth in higher concentrations of 3-amino-1,2,4-triazole demonstrates stronger binding. A,
Myosin Vc binds to constitutively active Rab7a, Rab8a, Rab32, and Rab38 but not with Rab11a or Rab27a. B, specificity of Rab interactions with class V Myosins.
Rab32 and Rab38 bind only to Myosin Vc, but Rab7a and Rab8a bind other class V myosins. C, mapping binding of Rab proteins to Myosin Vc tail. Regions in the
tail of Myosin Vc homologous to Myosin Va exons D, E, and F were removed from the full-length tail and tested in yeast two-hybrid assays with Rab7a, Rab8a,
Rab32, and Rab38. The binding site for Rab32 and Rab38 includes exon F, Rab8a and Rab38 require exon E, and Rab8 is the only one whose binding site includes
exon D. D, yeast two-hybrid assays with the full-tail (aa 898 –1742) or the globular (Glob.) tail (aa 1335–1742) of human Myosin Vc binding to human Rab
GTPases Rab8a, Rab17, Rab32, and Rab38 in the GTP-locked, constitutively active state (Gln-to-Leu mutations). E, Rab7a independently binds to the coiled-coil
(aa 898 –1350) and globular tail (aa 1335–1742) domains of Myosin Vc.
Myosin Vc in Lysosome-related Organelle Biogenesis
NOVEMBER 28, 2014 • VOLUME 289 • NUMBER 48 JOURNAL OF BIOLOGICAL CHEMISTRY 33517
Myosin Vc caused a significant increase in the amount of mel-
anin accumulated inside MNT-1 melanocytes (Fig. 3B). Trans-
mission-electron micrographs of control and Myosin Vc-defi-
cient cells demonstrated that the increase in melanin was due to
an increase in the abundance of pigmented stage III and IV
melanosomes (Fig. 3, D and E). Quantification of the number of
non-pigmented, stage II melanosomes identified by the pres-
ence of striations and Pmel17 immunogold labeling demon-
strated no difference between control and Myosin Vc-deficient
cells (Fig. 3, F and G). These results suggest Myosin Vc defi-
ciency may cause a defect in melanosome secretion, a misregu-
lation in melanosome biogenesis, or both. To test for a possible
secretion defect, the melanin content in the media of cultured
MNT-1 cells was quantified. Consistent with a secretion defect,
the culture media of Myosin Vc-deficient cells contained less
melanin than control cells (Fig. 3H).
An alternative approach to interfere with the function of
class V Myosins has been the overexpression of their tail
domain. This dominant negative strategy has been successfully
used to investigate Myosin Va, Myosin Vb, and Myosin Vc (54).
We thus utilized the same Myosin Vc tail-GFP construct pre-
viously used as a dominant negative (54), transfected MNT-1
melanocytes, and determined the amount of melanin accumu-
lated inside the cells (Fig. 3C). For comparison, parallel experi-
ments were carried out with MNT-1 cells overexpressing GFP
(control), full-length Myosin Vc-GFP, full-length Myosin Vb-
GFP, and Myosin Vc tail-GFP harboring a deletion of exon F,
the binding site for Rab32 and Rab38. Overexpression of Myo-
sin Vc-tail-GFP caused a significant increase in the melanin
accumulated by MNT-1 cells, whereas full-length Myosin Vc or
Myosin Vb did not (Fig. 3C). This result is consistent with the
Myosin Vc siRNA data described above (Fig. 3B) and further
shows that the phenotype is not due to up-regulation of Myosin
Vb. Importantly, the increase in intracellular melanin elicited
by overexpression of the Myosin Vc tail requires exon F, indi-
cating that this phenotype depends on the Myosin Vc interac-
tion with Rab32 and Rab38 (Fig. 3C). The dominant negative
strategy was also utilized as an alternative approach to test for
melanin secretion defect (Fig. 3I). The amount of melanin in the
culture media of MNT-1 cells overexpressing Myosin Vc-tail-
GFP was lower than cells overexpressing GFP (control), Myosin
Vc-GFP, and Myosin Vb-GFP. This result supports the secre-
tion defect observed upon Myosin Vc depletion by siRNA
described above (Fig. 3H) and indicates the phenotype is not
due to up-regulation of Myosin Vb. Furthermore, the decrease
in secreted melanin caused by overexpression of the Myosin Vc
tail depends on exon F, demonstrating that interference of
Myosin Vc function requires its interaction with Rab32 and
Rab38 (Fig. 3I).
Interestingly, the phenotype elicited by Myosin Vc deficiency
is different from that of Myosin Va deficiency, which results in
perinuclear clustering of melanosomes without significantly
affecting melanosome number (44, 51). Instead, Myosin Vc
deficient-MNT-1 cells showed no obvious defects in melano-
some localization but significantly increased the number of pig-
mented melanosomes (Fig. 3, D and E). The distinct phenotypes
of Myosin Va and Myosin Vc deficiency suggest that Myosin Vc
functions independently from Myosin Va in melanocytes.
Moreover, although Myosin Va localizes tightly to mature
melanosomes (45), subcellular fractionation of MNT-1 extracts
using sucrose density gradients and confocal fluorescence
microscopy studies showed the bulk of Myosin Vc does not
localize to melanosomes (Fig. 4, 5, and 6). Based on the fraction-
ation patterns of melanosome resident proteins such as tyro-
FIGURE 2. Mapping Myosin Vc binding sites on Rab32 and Rab38. A,
homology modeling of Rab32 onto the crystal structure of Rab4a (PDB 2BME)
with the residues mutated to alanine in B and C shown in stick represen-
tation. Point mutations causing loss of Myosin Vc binding are highlighted in
yellow (tyrosine-95) and green (valine-94), and those with no effect in pink.
Deletion of the leucine 131-glycine 134 loop (LPNG, pink) also did not have an
effect. Rab32 residue valine 94 (highlighted in green) is required for the bind-
ing of the Rab32 and Rab38 effector Varp. Homologous mutations were intro-
duced in Rab38. B, yeast two-hybrid assay of constitutively active Rab32
(Rab32Q85L) and Rab38 (Rab38Q69L) binding to Myosin Vc. Residues on the
surface of Rab32 and Rab38 were mutated to alanine as indicated. Mutation
of Rab32Q85L-Y95A and Rab38Q69L-Y79A specifically disrupt interaction
with Myosin Vc tail. C, yeast two-hybrid assays with mutations that disrupt
interactions with Rab32 and Rab38 effectors Varp and Myosin Vc. A longer
growth period was used to detect subtle defects in binding of Rab single and
double mutants.
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sinase, Tyrp1, Tyrp2, Pmel17, and Myosin Va, melanosomes
are concentrated in fractions 5–10 of the sucrose density gra-
dient, but Myosin Vc is largely found in fractions 1–3 and to a
lesser extent in fractions 4 – 6 (Fig. 4). Thus a small proportion
of Myosin Vc is associated with melanosomes at steady state or
the association is transient and does not withstand the lengthy
fractionation procedure. Myosin Vc largely co-fractionates
with cytosolic proteins, vesicles, and light organelles that are
obtained in the first fractions (64). Notice that in addition to a
cohort of Rab32 and Rab38 (and other Rabs) that co-fractionate
with melanosomes (fractions 5–10), a proportion of these Rabs
is obtained in lighter fractions, consistent with their known
Myosin Vc in Lysosome-related Organelle Biogenesis
NOVEMBER 28, 2014 • VOLUME 289 • NUMBER 48 JOURNAL OF BIOLOGICAL CHEMISTRY 33519
presence in small transport vesicles and early endosomal
domains (24, 25, 64). Consistently, live cell confocal fluores-
cence microscopy of MNT-1 cells expressing full-length Myo-
sin Vc-GFP and tyrosinase-Cherry showed a limited number of
structures where both proteins colocalized over time (Fig. 5A).
The overall colocalization between Myosin Vc-GFP and tyrosi-
nase-Cherry was 21  4% (Fig. 5A). Furthermore, the average
diameter of the Myosin Vc-GFP structures (371  139 nm; 682
structures from 8 cells) was smaller than the average diameter
of tyrosinase-Cherry structures (613  245 nm; 1198 structures
from 8 cells; significance at p  0.0001). At steady state tyrosin-
ase mostly labels mature melanosomes that are 400 –500 nm in
size as determined by electron microscopy (1, 4). The smaller
Myosin Vc-GFP structures are more consistent with vesicles
and early endosome organelle domains. Similar results were
obtained with MNT-1 cells expressing Myosin Vc-GFP and
Tyrp1-Cherry (Fig. 5B). Additionally, a low degree of colocal-
ization was observed between endogenous melanosome mark-
ers Pmel17 (25  3%), Tyrp1 (15  2%), or Rab27a (22  2%)
and endogenous Myosin Vc by confocal fluorescence micros-
copy of fixed and immunostained MNT-1 cells (Fig. 6).
Although the quality of the antibody staining on fixed samples
is not as good as the live cell imaging of overexpressed GFP/
Cherry-tagged proteins, both approaches suggest a low level of
Myosin Vc localization to melanosomes at steady state.
Together, these results do not support a direct role of Myosin
Vc in secretion of mature melanosomes. Rather, these results
suggest the accumulation of mature melanosomes is an indirect
effect of Myosin Vc deficiency in melanocytes. For example,
during melanosome biogenesis Myosin Vc could be involved in
vesicular transport of a cargo that is then required for melano-
some secretion.
Myosin Vc Functions in Cargo Trafficking to Melanosomes—
In melanocytes deficient in AP-1, AP-3, BLOC-1, or BLOC-2,
newly synthesized integral membrane protein cargo such as
tyrosinase and Tyrp1 are not properly sorted and accumulate in
early endosomal domains (10 –13, 74). This cargo can subse-
quently a leak into the recycling pathway to the plasma mem-
brane or enter into the degradative multivesicular body path-
way (see Fig. 10). Thus, as a consequence of disrupting the
normal transport from early endosomal domains to melano-
somes, cargo proteins can exhibit increased traffic via the
plasma membrane and/or are subjected to degradation. Mela-
nocytes isolated from AP-3-, BLOC-1-, or BLOC-2-deficient
mice showed both phenotypes (recycling through the plasma
FIGURE 4. Myosin Vc is not abundant in melanosome-enriched subcellu-
lar fractions, but Myosin Vc knockdown alters the distribution of a sub-
set of melanosomal proteins. Immunoblotting analysis of fractions
obtained from control (A) and Myosin Vc-deficient MNT-1 post nuclear super-
natants (B) subjected to subcellular fractionation with a 20 –55% sucrose gra-
dient. Fraction 1 corresponds to 20% sucrose and fraction 12–55% to sucrose.
In control cells, melanosome markers tyrosinase, Tyrp1, Tyrp2, and Pme17 are
enriched in fractions 5–10. A significant proportion of melanosome-associ-
ated Rabs, Rab7a, Rab8a, Rab32, Rab38, and Rab27a is also recovered in frac-
tions 5–10. Myosin Va is highly enriched in fractions 5–10, consistent with its
known localization to mature melanosomes. Myosin Vc is present primarily in
fractions 1–5 and most enriched in fractions 1 and 2, similar to Rab11a. Notice
the significant change in Tyrp1 and Vamp7 fractionation profile in Myosin
Vc-deficient cells (B) compared with control cells (A). In contrast, tyrosinase
and Rab11a are largely unchanged.
FIGURE 3. Myosin Vc knockdown causes accumulation of pigmented melanosomes and a defect in melanin secretion. A, immunoblotting analysis of
total cell extracts from MNT-1 cells subjected to control or Myosin Vc siRNA knockdown. Myosin Vc is highly depleted upon siRNA treatment, but Myosin Va and
Myosin Vb are enriched in extracts from Myosin Vc-deficient cells. B, melanin was extracted from control MNT-1 cells or cells deficient for Myosin Vc and
quantified by a spectrophotometric method. Error bars represent S.E. *, p  0.05, n  4 experiments. C, melanin was extracted from MNT-1 cells overexpressing
GFP (control) or the following GFP fusion proteins: full-length Myosin Vc (Myo Vc-GFP), the full tail of Myosin Vc (aa 898 –1742) (Myo Vc-tail-GFP), the full tail of
Myosin Vc carrying a deletion of exon F (Myo Vc-tailF-GFP), and full-length Myosin Vb (Myo Vb-GFP). Melanin was quantified by a spectrophotometric method.
Error bars represent S.E. *, p  0.05, n  3 experiments. D and E, control MNT-1 cells or cells deficient for Myosin Vc were subjected to high pressure freezing in
15% dextran (9 –11 kDa) in culture media, freeze-substitution in 0.25% glutaraldehyde, 0.1% uranyl acetate, and embedding in Lowicryl HM20 resin and
processed for thin-section transmission electron microscopy. Myosin Vc knockdown resulted in accumulation of pigmented (stage III and IV) melanosomes in
MNT-1 cells. Error bars represent S.E. *, p  0.0001, n 	 10 cells. Bars, 1 m. F and G, immunoelectron microscopy analysis of control MNT-1 cells or cells deficient
for Myosin Vc labeled with the HMB45 antibody to Pmel17 (arrows, 12-nm colloidal gold). Pigmented melanosomes comprise melanosomes at stages III and IV,
and Striated melanosomes reflects any organelle labeled with Pmel17 that has visible striations. Error bars represent S.E. *, p  0.0001, n 	 10 cells. Bars, 200 nm.
H, quantification of melanin secreted to the culture media by control MNT-1 cells or cells deficient for Myosin Vc. Error bars represent S.E. *, p  0.05, n  5
experiments. I, quantification of melanin secreted to the culture media by MNT-1 cells overexpressing GFP (Control) or the following GFP fusion proteins:
full-length Myosin Vc (Myo Vc-GFP), the full tail of Myosin Vc (aa 898 –1742) (Myo Vc-tail-GFP), the full tail of Myosin Vc carrying a deletion of exon F (Myo
Vc-tailF-GFP), and full-length Myosin Vb (Myo Vb-GFP). Error bars represent S.E. *, p  0.05, n  4 experiments.
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membrane and degradation) when Tyrp1 was analyzed (12,
13). Similarly, MNT-1 cells deficient for AP-1 accumulate
Tyrp1 in early endosomes (10). MNT-1 cells deficient in Rab32
and Rab38 showed a modest but epistatic increase in recycling
of Tyrp1 and degradation of tyrosinase and a drastic Rab32-
specific loss of Tyrp2 (24). Here, we sought to determine if
Myosin Vc deficiency also produces similar cargo trafficking
phenotypes.
First, immunoblotting analysis of total extracts from Myosin
Vc-deficient MNT-1 cells showed increased levels of tyrosin-
ase, Tyrp1, and Pmel17 and drastically decreased levels of
Tyrp2 compared with control cells (Fig. 7A). The increased
level of various melanosome resident proteins in Myosin Vc-
deficient cells likely reflects the substantial accumulation of
pigmented melanosomes. Hence, based on this assay it is
unclear if a trafficking defect exists for cargo such as tyrosinase.
However, the strong Tyrp2 phenotype resembles the result pre-
FIGURE 5. Myosin Vc shows limited colocalization with the melanin-syn-
thesizing enzymes tyrosinase and Tyrp1. Shown are spinning-disk confo-
cal fluorescence microscopy images of a live MNT-1 cell expressing full-length
Myosin Vc-GFP (5c) and the melanosome markers tyrosinase-cherry (A) or
Tyrp1-cherry (T; B). A, the main picture shows the first frame of a movie, and
the inset on the lower left corner shows examples of structures where the two
proteins colocalize (yellow arrows). The same region of the cell is shown in the
small panels on the right as a time series depicting five frames of the movie.
Images were acquired at a rate of 1 frame/s. B, the picture corresponds to the
first frame of a movie, and the panels on the upper right corner show examples
of structures were the two proteins colocalize (yellow arrows). The same
region of the cell is shown in the panels on the lower right corner as a time
series depicting six frames of the movie. Images were acquired at a rate of 1
frame/s.
FIGURE 6. Myosin Vc and Myosin Vb display limited colocalization with
melanosome markers. Confocal fluorescent microscopy images of fixed/
permeabilized MNT-1 cells immunolabeled for endogenous Myosin Vc
(Alexa- 488) (A, C, and E) or Myosin Vb (Alexa-488) (B, D, and F) and endoge-
nous melanosome markers Pmel17, Tyrp1, and Rab27a (Alexa-546). Both
Myosin Vc (A, C, and E) and Myosin Vb (B, D, and F) show partial colocalization
with early, Pmel17-labeled, melanosomes (A and B) and with more mature,
pigmented melanosomes with Tyrp1 and Rab27a labeling (C–F). G, quantifi-
cation of colocalization as determined with Slidebook software. Error bars
represent S.E., n  10 cells.
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viously reported for Rab32-deficient MNT-1 cells and supports
a role for Myosin Vc in transport to melanosomes.
Second, cell surface expression and recycling of Tyrp1 was
determined with MNT-1 cells deficient in Myosin Vc and con-
trol cells. Live cells were incubated with antibodies to the lumi-
nal domain of Tyrp1 for 20 min and then fixed/permeabilized
and processed for fluorescence microscopy (Fig. 7B). The total
fluorescence intensity signal per cell corresponds to the sum of
surface and internalized antibody and thus represents Tyrp1
undergoing recycling. This value is then corrected for the over-
all amount of Tyrp1 as determined by immunoblotting of total
cell extracts to account for differences in expression levels.
Myosin Vc deficiency produced a significant increase in Tyrp1
recycling suggesting Myosin Vc is involved in transport from
early endosomes to maturing melanosomes. To compare the
relative severity of the Tyrp1 recycling phenotype, similar
experiments were carried out in parallel with MNT-1 cells defi-
cient in AP-3 or simultaneously deficient in both Rab32 and
Rab38 (Fig. 7B). The Tyrp1 recycling phenotype of Myosin Vc-
deficient cells was more severe than the one observed in Rab32/
Rab38 double-deficient cells but less severe than in AP-3-defi-
cient cells assayed under the same conditions (Fig. 7B). These
differences may be secondary to different levels of depletion
obtained by the corresponding siRNA treatments or represent
true differences in the dependence of Tyrp1 traffic with each of
these proteins. Regardless, the data support a model in which
Myosin Vc functions in transport from early/recycling endo-
somes to maturing melanosomes (see Fig. 10). We also used the
dominant negative strategy of overexpressing the Myosin Vc
tail as another approach to test for Tyrp1 mistrafficking (Fig.
7C). Indeed, MNT-1 cells overexpressing Myosin Vc-tail-GFP
displayed significant Tyrp1 recycling (Fig. 7C). However, over-
expression of Myosin Vc-GFP, Myosin Vb-GFP, or Myosin Vc-
tail-GFP carrying a deletion of exon F did not show increased
FIGURE 7. Myosin Vc knockdown and overexpression of Myosin Vc-tail-
GFP disrupt trafficking of specific melanosomal cargoes. A, immunoblot-
ting analysis of total cell extracts from siRNA control- and Myosin Vc-treated
MNT-1 cells. Deficiency of Myosin Vc results in an accumulation of melanin
synthesizing enzymes tyrosinase and Tyrp1 but a severe reduction in Tyrp2.
Pmel17 is highly enriched in Myosin Vc-depleted samples. The experiments
were repeated at least three times with similar results. B, live MNT-1 control
cells or cells deficient for AP-3, both Rab32 and Rab38, or Myosin Vc were
incubated with culture media containing the MEL-5 (Ta99) mouse anti-Tyrp1
antibody for 20 min at 37 °C, subsequently fixed, permeabilized, and immu-
nostained with an Alexa-488-conjugated anti-mouse antibody. Cells were
imaged using an epifluorescent microscope, and the relative amounts of sur-
face and internalized anti-Tyrp1 antibody were estimated as the average fluo-
rescence intensity per cell determined with ImageJ and normalized to con-
trol cells (means  S.D.). Results from at least three independent experiments
were compared with control cells. *, p  0.01. C, live MNT-1 cells overexpress-
ing GFP (Control) or the following GFP fusion proteins: full-length Myosin Vc
(Myo Vc-GFP), the full tail of Myosin Vc (aa 898 –1742) (Myo Vc-tail-GFP), the full
tail of Myosin Vc carrying a deletion of exon F (Myo Vc-tailF-GFP), and full-
length Myosin Vb (Myo Vb-GFP) were subjected to the same anti-Tyrp1 anti-
body internalization assay described in B with the exception that cells were
immunostained with an Alexa-647-conjugated anti-mouse antibody. Result
from three independent experiments were compared with control cells.
*, p  0.05. D, immunoelectron microscopy analysis of control and Myosin
Vc-deficient MNT-1 cells labeled with the SYBL1 (158.2) antibody to Vamp7
(arrows, 18 nm). Vamp7 largely localizes to pigmented melanosomes in con-
trol MNT-1 cells (57  6% of the gold particles, 5 cells). Insets 1 and 2 show
examples of gold particles associated with stage III/IV melanosomes in con-
trol cell. Myosin Vc deficiency decreases the localization of Vamp7 to pig-
mented melanosomes (29  7% of the gold particles, 7 cells, p  0.001) and
increases its localization to the plasma membrane and vacuolar compart-
ments with morphological characteristics of endosomes (electron-lucent
interior with few or no intraluminal vesicles). Insets 3, 4, and 5 show examples
of gold particles associated with the plasma membrane, electron lucent vac-
uoles, and stage IV melanosomes, respectively, in a Myosin Vc-deficient cell.
Bars, 500 nm.
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Tyrp1 recycling relative to control (GFP) (Fig. 7C). The lack of a
recycling phenotype by overexpression of the later construct
indicates Myosin Vc function in Tyrp1 transport depends on its
ability to interact with Rab32 and Rab38.
Third, we investigated the SNARE protein Vamp7, consid-
ered to be both cargo and machinery of the pathway to mela-
nosomes and lysosomes (73, 75, 76). In MNT-1 cells, normal
steady state levels of Vamp7 depend on the BLOC-1 pathway,
and blockage of this pathway results in increased surface recy-
cling of Vamp7 (76). Furthermore, Vamp7 interacts physically
with AP-3 and with the Rab32 and Rab38 effector Varp, and
Vamp7 knockdown causes mistrafficking of Tyrp1 in melano-
cytes (73, 75, 77). Immunoblotting analysis showed increased
steady state levels of Vamp7 protein in whole-cell extracts from
Myosin Vc-deficient MNT-1 cells compared with control cells
(Fig. 7A). This result suggests a significant proportion of
Vamp7 may localize to pigmented melanosomes, which are
highly abundant in Myosin Vc-deficient cells. Furthermore,
Vamp7 distribution in sucrose gradient subcellular fraction-
ation assays (fractions 5–10) correlated tightly with the mela-
nosome resident proteins Pmel17, tyrosinase, Tyrp1, and
Tyrp2 (Fig. 4). Indeed, localization of Vamp7 by immunogold
electron microscopy of control MNT-1 cells revealed that 57 
6% of the label was associated with the limiting membrane of
pigmented melanosomes, whereas 40  5% of the label was
associated with other intracellular membranes (69 gold parti-
cles, 5 cells) (Fig. 7D). Based on the lack of staining of the
nucleus and mitochondria the nonspecific labeling was consid-
ered negligible, and only one gold particle was detected at the
plasma membrane. Despite the increased number of pigmented
melanosomes in Myosin Vc-deficient cells, only 29  7% of the
gold particles was associated with the limiting membrane of
pigmented melanosomes (245 gold particles, 7 cells; p  0.001,
Myosin Vc knockdown versus siRNA control). Moreover, gold
particles were abundant at the plasma membrane and vacuolar
compartments with morphological characteristics of endo-
somes (electron-lucent interior with few or no intraluminal
vesicles), likely reflecting increased recycling (Fig. 7D). From
these experiments we conclude that in melanocytes at steady
state a significant proportion of Vamp7 localizes to pigmented
melanosomes and that its traffic to the melanosome depends on
Myosin Vc (see Fig. 10).
Fourth, to test for Myosin Vc function in trafficking of Tyrp1
and Vamp7 to the melanosome with an independent approach,
we fractionated extracts of MNT-1 cells deficient in Myosin Vc
using sucrose density gradients (Fig. 4B). Although a cohort of
Tyrp1 and Vamp7 was detected in fractions 5–10 correspond-
ing to melanosomes, a significant proportion was found in
lighter membrane fractions demonstrating significant mislo-
calization. Interestingly, the bulk of tyrosinase fractionated as
in wild-type cells thus showing minimal mistargeting caused by
Myosin Vc deficiency (Fig. 4B). Defects in the trafficking path-
ways used by Tyrp1 and Vamp7, but not tyrosinase, suggest that
Myosin Vc functions in trafficking of a subset of cargoes from
early endosomal domains to maturing melanosomes (see Fig.
10). In further support of this idea we found that a proportion of
Myosin Vc-GFP localizes to early/recycling compartments in
MNT-1 cells as labeled with internalized transferrin (Fig. 8).
For this experiment, MNT-1 cells transfected with Myosin-Vc
(and Myosin Vb) were incubated for 20 min with transferrin-
Alexa 647, washed, and immediately observed by confocal
fluorescence microscopy. The overall colocalization between
Myosin Vc-GFP and transferrin-Alexa 647 was 28  7%. In
parallel experiments the well known component of the recy-
cling pathway, Myosin Vb, showed 62  9% colocalization with
transferrin-Alexa 647. Furthermore, Rab32 and Rab38 have
been shown to localize to early endosomal domains, transport
vesicles, and melanosomes (see Fig. 10). We found that Myosin
Vc-tail-GFP colocalized with Rab32-Cherry and Rab38-Cherry
to a significant degree in transfected MNT-1 cells (48  10%
and 51  8%, respectively) (Fig. 9). However, Myosin Vc-tailF-
GFP harboring a deletion of exon F only marginally colocalized
with Rab32 and Rab38 (17  6% and 14  5%, respectively) and
showed more cytosolic background staining (Fig. 9). From
these experiments we conclude that Myosin Vc functions in
transport of a subset of melanosomal integral membrane pro-
teins including Tyrp1 and Vamp7 from early endosomal
domains to maturing melanosomes. Fig. 10 shows a model
summarizing our interpretation of these results in the context
of previous knowledge of the transport routes to melanosomes.
DISCUSSION
Several studies have demonstrated that the biogenesis of
LROs in general and melanosomes in particular depends on a
combination of ubiquitous and cell type-specific trafficking
machinery (1, 14, 21–25, 27, 78). AP-1, AP-3, and the BLOCs
are well known examples of the ubiquitous machinery, and
Rab32 and Rab38 are key cell type-specific components. This
FIGURE 8. Myosin Vc-GFP shows partial colocalization with internalized
transferrin-Alexa-647. Shown are spinning-disk confocal fluorescence
microscopy images of live MNT-1 cells expressing full-length Myosin Vc-GFP
(A) or full-length Myosin Vb-GFP (B) after 20 min of incubation with transfer-
rin-Alexa-647 at 37 °C. Boxed areas are shown in the magnified bottom panels
and contain examples of structures were the two proteins colocalize (yellow
arrows).
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machinery defines multiple vesicular transport pathways from
specialized tubules and buds of the early endosomal system to
melanosomes for delivery of integral membrane proteins
required for organelle maturation and function (Fig. 10) (1, 27).
In this study we show that Myosin Vc is a new component of the
ubiquitous machinery that interacts physically and functionally
with cell type-specific Rab32 and Rab38 to mediate transport of
a subset of cargoes to maturing melanosomes and ultimately
facilitate organelle secretion.
We show that Rab32 and Rab38 interact with Myosin Vc
specifically when they are in the GTP-bound conformation and
do not bind the related Myosin Va and Myosin Vb. Our results
show that the interaction depends on the canonical switch II
surface region used by Rabs to interact with effector proteins
(71). These findings indicate Myosin Vc is likely one of the
effectors of Rab32 and Rab38. The interaction also depends on
regions of the coiled-coil domain of the Myosin Vc tail that have
been shown to be important for the function of other class V
Myosins (43, 69). Notably, Rab32 and Rab38 interaction with
Myosin Vc depends on its exon F region similar to the melano-
cyte splice form of Myosin Va that depends on exon F to bind
the Rab27/melanophilin complex and localize to melanosomes
(43). In support of the idea that the interaction between Rab32
and Rab38 with Myosin Vc is biologically relevant and that
Myosin Vc works in melanosome biogenesis, we show that a
deficiency of Myosin Vc in melanocytes causes similar mistraf-
ficking of a subset of melanosomal proteins, Tyrp1 and Tyrp2,
as a deficiency of Rab32 and Rab38 (24). First, knockdown of
Myosin Vc causes increased recycling of Tyrp1 through the
plasma membrane, a defect previously reported for Rab32- and
Rab38-deficient cells and reproduced here. Second, Myosin Vc
deficiency causes reduced overall Tyrp2 levels paralleling the
results previously obtained for Rab32-deficient melanocytes.
Third, increased accumulation of intracellular melanin,
decreased secretion, and abnormal Tyrp1 recycling phenotypes
occurred only with the full Myosin Vc tail construct but not
with the same Myosin Vc fragment lacking the binding site for
Rab32 and Rab38, exon F. Finally, Myosin Vc-tail-GFP colocal-
ization with Rab32 and Rab38 was dependent on the Myosin Vc
region encoded by exon F. These results imply that at least some
of Myosin Vc functions depend on Rab32 and Rab38. We also
FIGURE 9. Myosin Vc-tail-GFP shows partial colocalization with Rab32-
Cherry and Rab38-Cherry. Spinning-disk confocal fluorescence microscopy
images of live MNT-1 cells expressing the full tail of Myosin Vc (aa 898 –1742)
tagged with GFP (Myosin Vc tail) and Rab32-Cherry (Rab32) (A), the full tail of
Myosin Vc carrying a deletion of exon F tagged with GFP (Myosin Vc tail F)
and Rab32-Cherry (Rab32) (B), the full tail of Myosin Vc (aa 898 –1742) tagged
with GFP (Myosin Vc tail) and Rab38-Cherry (Rab38) (C), or the full tail of
Myosin Vc carrying a deletion of exon F tagged with GFP (Myosin Vc tail F)
and Rab38-Cherry (D). Boxed areas in A and C are shown in the magnified
panels and contain examples of structures were the two proteins colocalize
(yellow arrows).
FIGURE 10. Model for Myosin Vc-dependent and Myosin Vc-independent
transport pathways to maturing melanosomes. Myosin Vc interacts with
components of the trafficking machinery such as Rab32 and Rab38 at early/
recycling endosome membrane domains where a subset of cargoes includ-
ing Tyrp1 and Vamp7 (and possibly Tyrp2) is concentrated and packaged into
vesicles for transport to maturing melanosomes. Myosin Vc does not partici-
pate, however, in pathways that deliver other melanosomal cargo such as
tyrosinase. Unlike adaptor proteins (AP-1, AP-3) and clathrin that typically
dissociate from the vesicle, Myosin Vc may remain bound to mediate vesicle
transport and/or tethering to melanosomes. Myosin Vc deficiency elicits
accumulation of cargo (such as Tyrp1, Vamp7, and possibly Tyrp2) in early/
recycling endosomes that eventually leak into the recycling pathway to the
plasma membrane or the late endosome/multivesicular body (MVB) degra-
dative pathway. A component of the melanosome secretion machinery such
as Vamp7 is not adequately incorporated into melanosomes in Myosin Vc-
deficient cells causing accumulation of pigmented melanosomes within
melanocytes.
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show that in control melanocytes a significant proportion of
Vamp7 localizes to pigmented, stage III and IV melanosomes,
but in Myosin Vc-deficient cells Vamp7 localization is abnor-
mal and consistent with increased recycling. This is in line with
previous reports showing Vamp7 trafficking phenotypes in
non-specialized cells from AP-3 knock-out mice and in MNT-
1 cells with a defective BLOC-1 pathway (76). However, it is
not clear if Rab32 and Rab38 are needed for Vamp7 transport
in melanocytes. Despite the abnormal traffic of some cargoes to
melanosomes, Myosin Vc-deficient cells produce pigmented
melanosomes. This is also the case with melanocytes from mice
and patients deficient for AP-3, Rab38, and other components
of the biogenesis machinery as well as MNT-1 cells depleted for
AP-1 (10, 21, 29). The existence of multiple parallel trafficking
pathways that deliver cargo to maturing melanosomes allows
for enough traffic to produce pigmented melanosomes even
when some of the pathways are defective. However, cargoes
display different levels of dependence on the various parallel
pathways and tyrosinase and Tyrp1 show little overlap (1) (Fig.
10). Notably, the trafficking of tyrosinase is largely unaffected
by Myosin Vc deficiency (Fig. 4). This result explains the pro-
duction of pigmented melanosomes in Myosin Vc-deficient
MNT-1 cells because tyrosinase is the key enzyme in melanin
synthesis, whereas Tyrp1 and Tyrp2 serve modulatory roles (1,
3, 9). In contrast Rab32 and Rab38 (and AP-3) are involved in
the transport of both tyrosinase and Trp1 (11, 25, 27, 31), sug-
gesting that Rab32 and Rab38 serve both MyosinVc-dependent
and Myosin Vc-independent functions in melanosome biogen-
esis. Conversely, Myosin Vc may have Rab32/Rab38-indepen-
dent functions, thus causing only partially overlapping pheno-
types when either the Rabs or Myosin Vc are deficient. For
example the interaction between Myosin Vc with Rab7 and
Rab8 may mediate some Myosin Vc functions that are Rab32/
Rab38-independent. The trafficking route followed by Tyrp2 is
not nearly as well understood as those of tyrosinase and Tyrp1.
For example, it has not been shown if Tyrp2 also traffics
through the early/recycling endosomal system like tyrosinase
and Tyrp1. In the future it will be important to clarify the trans-
port route for Tyrp2, which appears to differ from Tyrp1 and
tyrosinase based on this work and published data (24, 27). Nev-
ertheless, the drastic reduction of Tyrp2 steady state level
caused by Myosin Vc deficiency (Fig. 7) is remarkably similar to
that elicited by Rab32 deficiency (24, 27). In contrast, Tyrp2 is
unaffected by Rab38 deficiency, suggesting a closer functional
relationship between Myosin Vc and Rab32 than Rab38 (24).
These cargo trafficking data together with the physical
interactions and colocalization results are most consistent
with a model in which Myosin Vc functions in pathways from
early/recycling endosome-associated tubules to maturing
melanosomes (Fig. 10). Such a location fits well with the estab-
lished model for transport of Tyrp1 from early endosomes to
maturing melanosomes. This model also explains the data on
Vamp7 transport to melanosomes and places Myosin Vc as
acting from early/recycling endosomes with potential roles in
vesicle scission, motility, and docking events. This model also
provides a satisfactory explanation to the observed cargo phe-
notypes upon interfering with Myosin Vc function by siRNA or
dominant negative approaches. Disruption of transport from
early/recycling endosomes toward melanosomes causes
accumulation of the cargo in early endosomes and leakage
into the recycling pathway to the plasma membrane and/or
into the degradative multivesicular body/lysosomal pathway.
The model is compatible with only partial Myosin Vc colocal-
ization with the early/recycling endosome marker, transferrin,
and mature melanosome markers, tyrosinase and Tyrp1, as
these would represent the start and end point of the Myosin Vc
transport pathway (Fig. 10). The presence of Myosin Vc in
transport vesicles moving from early/recycling endosomes to
melanosomes would fit the small average size of structures dec-
orated by Myosin Vc-GFP as well as the presence of endoge-
nous Myosin Vc in fractions of low sucrose density.
Interestingly, Myosin Vc deficiency elicits abnormal accu-
mulation of pigmented melanosomes within melanocytes. This
is evidenced by the increase in total melanin, the number of
pigmented melanosomes (but not of their unpigmented pre-
cursors), and the steady state levels of several melanosome res-
ident proteins. The accumulation of pigmented melanosomes
in Myosin Vc-deficient cells indicates Myosin Vc may function
in melanosome secretion in addition to melanosome biogene-
sis. Accordingly, the amount of melanin secreted by Myosin
Vc-deficient MNT-1 cells was lower than in control cells (Fig.
3). Importantly, Myosin Vc is not abundant on melanosomes,
arguing against a direct function of Myosin Vc in secretion.
Rather, the data suggest a role for Myosin Vc in the traffic of a
melanosome component that may be required for proper secre-
tion. Vamp7 could be such component as it was previously
shown to mediate exocytosis of lysosomes and LROs in several
cell types, and we found it to be abundant on mature melano-
somes in control cells but mislocalized in Myosin Vc-deficient
cells (80). In the skin, melanocytes transfer mature melano-
somes to keratinocytes by a poorly understood mechanism.
Several different possibilities have been proposed ranging from
the exocytosis of naked melanin by melanocytes and subse-
quent endocytosis by neighboring keratinocytes to the shed-
ding of melanosome-rich packages by melanocytes coupled to
phagocytosis by adjacent keratinocytes (36 – 41). A role for
Vamp7 (or other vSNAREs (vesicle SNAREs)) could be easily
envisioned in a scenario where fusion of the melanosome mem-
brane with another membrane, such as the melanocyte plasma
membrane, is involved in the secretion or transfer mechanism.
We thus reason that an indirect function on Myosin Vc in mela-
nosome secretion is more likely but do not rule out the possi-
bility of a direct role.
Several other Rab proteins have been localized to melano-
somes or implicated in their biology. Rab11 was reported to
participate in the exocytosis of melanosomes via the naked mel-
anin mechanism (36). Rab17 was shown to operate in the for-
mation of melanocyte filopodia as conduits for melanosome
secretion (37). The lack of interaction of Myosin Vc with Rab11
or Rab17 suggests the function ascribed to these Rabs in mela-
nosome secretion is independent of Myosin Vc. Another pair of
relevant Rabs is that of Rab7a and Rab8a, which in melanocytes
localize to immature and mature melanosomes, respectively
(66, 67). In this context the interaction between these Rabs and
Myosin Vc (Fig. 1) could be important for melanosome biogen-
esis. Therefore, in addition to tissue-specific Rab32 and Rab38,
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ubiquitous Rab7a and Rab8a could cooperate with Myosin Vc
during melanosome biogenesis. Our mapping experiments
indicate that Rab7a binds to regions of the Myosin Vc tail not
overlapping with Rab8a, Rab32, and Rab38 and that Rab8a
overlaps only with Rab38. Therefore, several of these Rabs
could simultaneously bind Myosin Vc.
An interesting observation is that the levels of Myosin Va and
Myosin Vb are higher in Myosin Vc-deficient MNT-1 melano-
cytes (Fig. 3A). As Myosin Va is found on pigmented melano-
somes, the increase in Myosin Va observed in Myosin Vc-defi-
cient cells may be caused by the increase in pigmented
melanosomes. Alternatively, the higher Myosin Va level might
reflect compensation for the loss of Myosin Vc function by up-
regulation of Myosin Va. The latter possibility would suggest
that some degree of redundancy exists in the functions of Myo-
sin Vc with Myosin Va. However, Myosin Va deficiency results
in perinuclear clustering of melanosomes without affecting
melanosome number (44, 51). Instead, Myosin Vc-deficient
MNT-1 cells show no obvious defects in melanosome localiza-
tion but significantly increased the number of pigmented mela-
nosomes. Furthermore, although Myosin Va does not operate
in the biogenesis of melanosomes, our data revealed a function
for Myosin Vc in transport of several cargoes to melanosomes.
Thus, the distinct phenotypes observed for melanocytes defi-
cient in Myosin Va and Myosin Vc suggest that Myosin Vc
functions independently from Myosin Va in melanocytes. It is
unclear if the higher level of Myosin Vb in cells deficient for
Myosin Vc is due to Myosin Vb localization and function on
mature melanosomes or if Myosin Vb is up-regulated to func-
tionally compensate for Myosin Vc deficiency. Our results
show only low levels of colocalization between Myosin Vb and
melanosome markers Pmel17, Tyrp1, and Rab27 in fixed and
immunostained MNT-1 cells (Fig. 6). Importantly, overexpres-
sion of Myosin Vb-GFP did not cause the increased melanin
accumulation within MNT-1 cells, the decreased melanin
secretion, or Trp1 recycling observed upon Myosin Vc deple-
tion, thus ruling out up-regulation of Myosin Vb as a cause for
these phenotypes (Figs. 3 and 7).
Interestingly, another effector of Rab32 and Rab38, Varp, was
shown to participate in Tyrp1 traffic to melanosomes (73, 81).
Furthermore, Varp binds to Vamp7 and traps it in a closed,
fusogenically inactive conformation (75). Therefore, both
Rab32 and Rab38 effectors, Myosin Vc and Varp, may function
in the same trafficking pathway from early endosome tubules
and buds to melanosomes. Myosin Vc and Varp bind to an
overlapping region on the surface of Rab32 and Rab38, suggest-
ing mutually exclusive binding and thus sequential function
during transport to melanosomes (Fig. 2) (73). If Myosin Vc and
Varp interact with Rab32 and Rab38 during discrete steps, it is
not obvious which effector would act upstream. Myosin Vc
could function during budding of a transport intermediate
from the early endosomal system, perhaps upstream Varp.
Alternatively, Myosin Vc could compete out Varp, thus releas-
ing Vamp7 from its closed conformation, to foster tethering/
fusion of a transport intermediate with the maturing melano-
some. Interestingly, Myosin Va was shown to tether synaptic
vesicles to the plasma membrane such that vesicles are poised
for fusion upon rise in Ca2 concentration (79, 82). Myosin Vc
could have an analogous role in tethering transport vesicles to
melanosomes. The link between Myosin Vc, Varp, and the Rabs
in the biogenesis of melanosomes and other LROs warrants
future investigation.
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